Amount Raised
$150 Million
Round Type
Series B
CambridgeBiotechnologyHealth CareScience And EngineeringDescription
MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease, today announced the completion of a $150 million Series B financing. The financing was led by Goldman Sachs Asset Management, with participation from other new investors Section 32, Pavilion Capital, Invus and LifeSci Venture Partners. All of MOMA’s Series A investors, including Third Rock Ventures, Nextech Invest, Cormorant Asset Management, Casdin Capital, Rock Springs Capital, Creacion Ventures, Alexandria Venture Investments and other undisclosed investors, also participated in the round.
Quick answer
Moma Therapeutics raised $150 Million in a Series B round, dated May 10, 2022. Moma Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Moma Therapeutics raise?
- Moma Therapeutics raised $150 Million in a Series B round on May 10, 2022.
- What does Moma Therapeutics do?
- MOMA Therapeutics is committed to discovering the next generation of precision medicines by targeting molecular machines that underlie human disease.
- Where is Moma Therapeutics based and how big is it?
- Moma Therapeutics is based in Cambridge, Massachusetts, United States.
- Who are the decision-makers at Moma Therapeutics?
- Fundz holds 1 contact at Moma Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Moma Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- PineTree Therapeutics raised $24M (Series A) on June 7, 2022.
- Upstream Bio raised $200M (Series A) on June 2, 2022.
- 22nd Century raised $58M on May 25, 2022.
- OliX Pharmaceuticals raised $45M (Funding Round) on May 25, 2022.
- Vyriad raised $30M (Series B) on May 17, 2022.
- Sequentify raised $7M (Funding Round) on May 10, 2022.
Who to call at Moma Therapeutics, and when
A new round usually means Moma Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Moma Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Moma Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Moma Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Moma Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMoma Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.